Cases of Aristolochic acid nephropathy (AAN) have been reported worldwide, yet no serum or urinary biomarkers have been shown to have clinical utility in detection of AAN. In this study, we aim to detect renal changes in the early phase of AAN with T2 mapping. The results suggest that T2 mapping may be a valuable tool in experimental studies and clinical practice of acute phase of AAN.
This abstract and the presentation materials are available to members only; a login is required.